论文部分内容阅读
本刊2009年2月上半期辩论会栏目刊发了《该不该要求中药新药研发进行临床试验》一文。为此,北京市昌平区读者常醴澄致函本刊,结合自己的行医实践和研究成果,表达了对此问题的一些看法。本刊在此刊出常先生的来信,并欢迎更多读者积极参与相关问题的讨论。顺便说明一点:作为本刊特色栏目,辩论会旨在为针锋相对的甲乙双方提供充分表达观点的平台,任何一方观点既不代表编辑也不代表本刊。常先生文中所说的“该文章”的观点仅为文章中的“甲方观点”。
In the first half of the February 2009 debate, the magazine published the article “This should not require clinical trials of Chinese medicines for new drug development”. To this end, readers of Changping District, Beijing Municipality, Chang Chengcheng wrote a letter to the journal, combining their own practice and research results, expressed some views on this issue. The journal hereby publishes Mr. Chang’s letter and welcomes more readers to actively participate in the discussion of relevant issues. Incidentally, one point: As a featured section of this journal, the debate is intended to provide a platform for the diametrically opposed parties A and B to fully express their opinions. The opinions of either party neither represent the editor nor the journal. The view of “this article” mentioned by Mr. Chang is only the “Party’s point of view” of the article.